Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-04
2005-01-04
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S063000, C514S423000, C548S406000, C548S523000, C548S526000, C548S537000
Reexamination Certificate
active
06838478
ABSTRACT:
There is provided compounds of formula I,wherein R1, R2, R3, Rx, Y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
REFERENCES:
patent: 4346078 (1982-08-01), Bajusz et al.
patent: 4703036 (1987-10-01), Bajusz et al.
patent: 5187157 (1993-02-01), Kettner et al.
patent: 5260307 (1993-11-01), Ackermann et al.
patent: 5405854 (1995-04-01), Ackermann et al.
patent: 5510369 (1996-04-01), Lumma et al.
patent: 5559232 (1996-09-01), Ackermann et al.
patent: 5561146 (1996-10-01), Kim et al.
patent: 5583146 (1996-12-01), Kimball et al.
patent: 5602253 (1997-02-01), Antonsson et al.
patent: 5614499 (1997-03-01), Bylund et al.
patent: 5629324 (1997-05-01), Vacca et al.
patent: 5705487 (1998-01-01), Schacht et al.
patent: 5707966 (1998-01-01), Schacht et al.
patent: 5710130 (1998-01-01), Schacht et al.
patent: 5723444 (1998-03-01), Antonsson et al.
patent: 5726159 (1998-03-01), Schacht et al.
patent: 5736521 (1998-04-01), Bylund et al.
patent: 5741792 (1998-04-01), Kimball et al.
patent: 5741799 (1998-04-01), Kimball et al.
patent: 5744487 (1998-04-01), Ohshima et al.
patent: 5747460 (1998-05-01), Bylund et al.
patent: 5780631 (1998-07-01), Antonsson et al.
patent: 5783563 (1998-07-01), Antonsson et al.
patent: 5852051 (1998-12-01), Bohm et al.
patent: 5856307 (1999-01-01), Antonsson et al.
patent: 5914319 (1999-06-01), Schacht et al.
patent: 5932637 (1999-08-01), Ito et al.
patent: 5939392 (1999-08-01), Antonsson et al.
patent: 5955433 (1999-09-01), Bylund et al.
patent: 5965692 (1999-10-01), Gustafsson et al.
patent: 6030972 (2000-02-01), Bohm et al.
patent: 6337394 (2002-01-01), Karlsson et al.
patent: 20010046981 (2001-11-01), Karlsson et al.
patent: 0 185 390 (1986-06-01), None
patent: 0 185 390 (1986-06-01), None
patent: 0 195 212 (1986-09-01), None
patent: 0 195 212 (1986-09-01), None
patent: 0 293 881 (1988-12-01), None
patent: 0 362 002 (1990-04-01), None
patent: 0 364 344 (1990-04-01), None
patent: 0 364 344 (1990-04-01), None
patent: 0 468 231 (1992-01-01), None
patent: 0 468 231 (1992-01-01), None
patent: 0 526 877 (1993-02-01), None
patent: 0 526 877 (1993-02-01), None
patent: 0 530 167 (1993-03-01), None
patent: 0 542 525 (1993-05-01), None
patent: 0 559 046 (1993-09-01), None
patent: 0 601 459 (1994-06-01), None
patent: 0 623 596 (1994-11-01), None
patent: 0 641 779 (1995-03-01), None
patent: 0648780 (1995-04-01), None
patent: 0 669 317 (1995-08-01), None
patent: 0672658 (1995-09-01), None
patent: 0686642 (1995-12-01), None
patent: 9311152 (1993-06-01), None
patent: 9318060 (1993-09-01), None
patent: 9429336 (1994-12-01), None
patent: 9523609 (1995-09-01), None
patent: 9535309 (1995-12-01), None
patent: 9603374 (1996-02-01), None
patent: WO 9617860 (1996-06-01), None
patent: WO 9624609 (1996-08-01), None
patent: 9625426 (1996-08-01), None
patent: WO 9631504 (1996-10-01), None
patent: 9632110 (1996-10-01), None
patent: 9702284 (1997-01-01), None
patent: 9223499 (1997-07-01), None
patent: WO 9723499 (1997-07-01), None
patent: WO 9806740 (1998-02-01), None
patent: WO 9806741 (1998-02-01), None
Markwardt, F., et al; “Synthetic Low Molecular Weight Inhibitors of Serum Kallikrein”; Biochem. Pharm., vol. 23, pp. 2247-2256 (1974).
Claesson, “Synthetic peptides and peptidomimetics . . . ,” Blood Coagul. Fibronol., vol. 5, p. 411 (1994).
Blomback et al, “Synthetic Peptides with . . . ,” J. Clin. Lab. Invest., vol. 24, suppl. 107, p. 59 (1969).
Labes et al, “Free-Wilson Analysis of the Inhibitory Effect of 4-Substituted Benzamidines . . . ,” Pharmazie, vol. 34, No. 9, pp. 554-556 (1979).
Gustafsson David
Nyström Jan-Erik
AstraZeneca AB
Nixon & Vanderhye
Stockton Laura L.
LandOfFree
Amino acid derivatives and their use as thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid derivatives and their use as thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid derivatives and their use as thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3399503